Author: P&S Intelligence

Consumption Status and Analysis Forecast

Synovial Sarcoma Therapeutics Pipeline Analysis 2019

Synovial sarcoma is a soft-tissue sarcoma, which is divided into four stages (I, II, III, and IV) depending on the size of tumor. The growth of the tumor tends to cause numbness and pain in joints when it presses against nerves. The translocation between chromosomes X and 18 is expected to be responsible for causing…
Read more

Rhabdomyosarcoma (RMS) Therapeutics Pipeline Analysis 2019

Rhabdomyosarcoma (RMS) is a type of cancer that usually affects children. Soft tissues or hollow organs such as bladder or uterus are often affected by this disease. There are mainly two types of RMS: embryonal RMS (ERMS) and alveolar RMS (ARMS). Other types include anaplastic RMS and undifferentiated sarcoma. Depending on the type, RMS is…
Read more

Psoriasis Therapeutics Pipeline to Witness Significant Growth due to Positive Clinical Results in the Coming Years

Psoriasis is identified as a condition which causes chronic inflammation and scaling on skin. It develops when skin cells grow rapidly below the surface of the skin and get deposited on the surface before they get matured. In general, this deposition of cells takes a month time however, in psoriasis it may occur within few…
Read more

Retinitis Pigmentosa (RP) Therapeutics Pipeline to Witness Remarkable Growth due to Increased Number of Pipeline Candidates by Drug Developers

Retinitis pigmentosa (RP) is a group of hereditary disorders that lead to the breakdown and loss of cells in the retina. Mutation in genes encoding the proteins required by retinal cells for their proper functioning, results in occurrence of RP. The disease results in partial vision loss during the earlier stage of the disease, which…
Read more

Ulcerative Colitis (UC) Therapeutics Pipeline to Witness Significant Growth due to Positive Clinical Results in the Coming Years

Ulcerative colitis (UC) is a disease that affects colon or large intestine and results in inflammation of the colon and development of ulcers on intestinal linings. The disease is a result of improper functioning of immune system. As a repercussion, white blood cells (WBCs) reach the lining of large intestine, resulting in its inflammation. Signs…
Read more

Friedreich’s Ataxia (FRDA) Therapeutics Pipeline to Witness Significant Growth due to Positive Clinical Results in the Coming Years

Friedreich’s ataxia (FRDA) is an inherited autosomal recessive genetic condition that progressively damages the nervous system, with a typical age of onset between 10 years and 15 years. The risk factors associated with FRDA are diabetes mellitus and heart diseases, including cardiomyopathy and cardiac arrhythmias. FRDA occurs due to mutation in the frataxin (FXN) gene,…
Read more

Post-Operative Pain Therapeutics Pipeline to Witness Significant Growth due to Positive Clinical Results in the Coming Years

Post-operative pain is a very common problem experienced by patients who undergo surgical procedures. Pain is an unpleasant sensory and emotional experience caused by any injury, disease, or surgical procedure. Pain can be acute or chronic, depending upon the time it lasts. Acute pain is an unpleasant sensory, and emotional and mental sensation, which usually…
Read more

Achondroplasia Competitive Landscape: Do You Really Need It? This Will Help You Decide!

Achondroplasia therapeutics currently exhibits a considerably strong pipeline with seven active drug candidates. Achondroplasia is a common disorder of dwarfism with disproportionate stature. It is an autosomal dominant disorder that occurs due to mutation in fibroblast growth factor receptor 3 (FGFR3) gene, which is located on short arm of chromosome 4. The disorder is characterized by…
Read more

Want to know about pipeline analysis of p53 Antigen Modulators Therapeutics? Read This!!!

p53 is the tumor suppressor transcription factor that activates to various stimulus, including uncontrolled cell proliferation, oncogene over-expression, and DNA damage. p53 antigen modulators helps in preventing cancer development through regulation of cell cycle and apoptosis. Download the sample report @ https://www.pharmaproff.com/request-sample/1195 Thus, new opportunities in cancer immunotherapy are expected to develop better drug candidates…
Read more

Discover the detailed overview of Hormone Sensitive Breast Cancer, highlighting the causes, risk factors, classification, prognosis, pathophysiology, unmet medical needs, diagnosis, treatment options

Breast cancer generally occurs when breast cells grow uncontrollably. Mostly, breast cancer development starts in the duct that carries milk to the nipples. Download the sample report @ https://www.pharmaproff.com/request-sample/1114 Some breast cancer cells develop in milk producing glands. As per the National Institutes of Health (NIH), in the U.S., 14.6% of all new cancer cases…
Read more